Catalyst Wire Dossier Catalyst Wire Dossier

Vildagliptin/glimepiride

Vildagliptin/glimepiride · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vildagliptin/glimepiride, covering 2017-07-11 to 2017-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride [Phase 4]

See pricing